Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management and treatment of breast cancer.
Funds vital medical research into the detection and treatment of prostate cancer, as well as preventing the metastatic spread of the disease.
We are passionate and determined to improve heart health and beat heart disease through advances in knowledge and research.
Our aim is to reduce and ultimately eliminate the high incidence of chronic kidney disease and diabetes in Australia and around the world.
Supports health and wellbeing research for veterans, emergency service personnel and their families.
Driving collaboration, innovation and research to develop best-practice arts, design and health programs.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
A dedicated and passionate Professor Doug Brooks from the University of South Australia’s School of Pharmacy and Medical Sciences is making inroads in prostate cancer research, which has the potential to improve the way men are managed when diagnosed with prostate cancer.
The Hospital Research Foundation (THRF) is proud to have made a significant contribution, with the University of South Australia (UniSA), towards the purchase of a 3D Histech Panoramic confocal scanner, which will assist Prof Brooks and his team in imaging prostate cancer using a high-tech system.
The new histology technique (the study of cells in body tissue) and 3D scanner have the potential to confirm if a man has prostate cancer and also if it’s benign or aggressive, something that is currently difficult to determine and can lead to inaccurate results.
Prostate cancer can be detected by a blood PSA test, however it is not always accurate. In addition, doctors are unable to confirm from PSA levels how aggressive the cancer is, and this often results in radical treatments, which may not be necessary. This understandably creates an enormous amount of stress and uncertainty for the patient and their loved ones, which they shouldn’t have to experience.
“The 3D scanner will help us to change the way men are managed with prostate cancer and help eliminate the chances of misdiagnosis through PSA levels,” Prof Brooks said.
“This scanner will be used to confirm the diagnosis and to visualise the size and structure of the cancer, and see if it is an aggressive cancer, enabling doctors to choose the correct treatment method for the individual patient.
This vital research would not be possible without this state-of-the-art imaging machine, taking approximately 40,000 images per tissue sample that is then pieced together to produce a very high quality image. This machine will allow Prof Brooks to develop these new methods for prostate cancer patients, enabling better detection and disease prediction.
“This technology enables us to be one step closer to better diagnosis and treatment methods for men suffering prostate cancer, which is an urgent need” Prof Brooks said.
“A specific infrastructure requirement was identified that would boost our imaging capacity, so thanks to the generosity of THRF and their public supporters, the equipment can now be used to facilitate the technology development in a pre-clinical study, ready for use in clinical settings,” Prof Brooks said.
Around 1,000 tissue samples from both Ireland and Adelaide will be scanned using this machine, enabling Prof Brooks to complete this pre-clinical study in the next six months to validate his claims that this machine and the technology can be used to help prostate cancer patients.
“Although these new imaging technologies have specific applications for prostate cancer, the technology will be applied to other cancers, giving this project wider potential in cancer imaging.”
It is because of your support that Prof Brooks and his team will change the way clinicians and doctors diagnose and treat men suffering from prostate cancer, giving them accurate information to improve their outcomes and ultimately save lives.
Would you like to support vital research like Prof Brooks' today?
An exciting study is underway that could potentially lead to new treatments for metastatic prostate cancer (cancer that spreads around the body) at the Centre for Cancer Biology (CCB). read more
It was another incredible effort by the Ladies Auxiliary of the Cyprus Community who raised $3,500 for vital research into prostate cancer through The Hospital Research Foundation (THRF). read more
The Hospital Research Foundation (THRF) is proud to provide $250,000 to enable the purchase of a 3D scanner set to revolutionise the way prostate cancer is diagnosed and treated. read more
An exciting project set to explore a newly discovered pathway that could lead to new treatments for metastatic prostate cancer is now underway at the Centre for Cancer Biology. Supported by The Hospital Research Foundation, with partner Australian Prostate Cancer, this incredible, innovative research is set to save lives. read more
Ground-breaking research is underway boosting the body’s own immune system to fight the most common cancers affecting Australian families, including breast cancer. The treatment is known as immunotherapy, and whilst it’s currently revolutionising blood cancer treatment, when it comes to solid cancers like breast cancer it’s not known to be as effective. read more
Based at the Basil Hetzel Institute for Translational Health Research (BHI), breast cancer researcher Irene Zinonos is now part of a collaborative word-first prostate cancer research project. Led by the University of Adelaide’s Associate Professor Lisa Butler, this project aims to help quickly identify life-threatening cases of prostate cancer, compared with cancer that may not require treatment. read more
A Prostate Cancer Researcher at the University of Adelaide and winner in THRF’s 50th Anniversary Awards, Dr Rajdeep Das’s research will open up new and exciting avenues for personalised cancer medicine for prostate cancer patients. read more
After losing their beloved ‘Papou’, Georgios, to prostate cancer at the age of 86, the Panagiotidis grandchildren are very passionate about their family donation of $10,000 to The Queen Elizabeth Hospital (TQEH) Palliative Care Unit. read more
Online resource PROSTMATE is making a huge difference to patients and families dealing with prostate cancer. PROSTMATE is partly funded by The Hospital Research Foundation’s disease specific affiliate Australian Prostate Cancer, in collaboration with Australian Prostate Cancer Research. read more